Q4 2023 Crinetics Pharmaceuticals Inc Earnings Call Transcript
Welcome to the Chronix Pharmaceuticals Fourth Quarter and Full Year 2023 financial results conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a question and answer session. I will now turn the call over to Corey Davis of LifeSci Advisors. Please go.
Thank you, Sergio, and hello, everyone. Joining me on the call today are Scott Struthers, Founder and Chief Executive Officer, Alan Krasner, chief endocrinologist, and Mark Wilson, Chief Financial Officer. Also joining us for the Q&A portion of the call are Dana pursued a Chief Medical and Development Officer, and Jim has Chief Commercial Officer. A press release announcing the fourth quarter and full year 2023 financial results was issued today and is also available on the kinetics website.
As a reminder, we'll be making forward-looking statements, and I invite you to learn more about the risks and uncertainties associated with these statements.
As disclosed in our SEC filings. Such forward-looking statements are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |